Cardiac Simulator for Surgical Planning
Launched by STANFORD UNIVERSITY · Apr 16, 2024
Trial Information
Current as of July 28, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Cardiac Simulator for Surgical Planning" is designed to see if a special computer program can help doctors plan surgeries better for children with congenital heart disease. The main goal is to find out if using this software can reduce the number of unsuccessful surgeries and the need for repeat surgeries in young patients. The program allows surgeons to test different surgical methods in a safe, computer-simulated environment, helping them to better understand the best approach for each child's unique heart condition.
Eligible participants are children aged 0 to 17 who have specific types of congenital heart disease, such as congenitally corrected transposition of the great arteries or double outlet right ventricle. When families agree to join the trial, there’s a 50% chance their child will either receive the usual surgical planning discussions or the enhanced discussions using the computer simulator. If their child is in the simulator group, they will learn about the insights gained from the computer simulation during their planning meeting. This trial is not yet recruiting participants, but it aims to improve surgical care for children with complex heart conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The inclusion criteria are pediatric patients ages 0-17 with a congenital heart disease (CHD) diagnosis of 1) congenitally corrected transposition of the great arteries (cc-TGA) with ventricular septal defect (VSD), 2) double outlet right ventricle (DORV) with remote VSD, or 3) other single ventricle conditions.
- Exclusion Criteria:
- • Adult patients with CHD.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Alison Marsden, PhD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported